Popovski, D., Cochrane, C. R., Algar, E. M., Szczepny, A., Jayasekara, W. S., Ashley, D. M., … Cain, J. E. (2017). PDTM-06. TARGETED CATALYTIC INHIBITION OF EZH2 SYNERGIZES WITH LOW-DOSE PANOBINOSTAT IN MALIGNANT RHABDOID TUMOR. In Neuro-Oncology (Vol. 19, pp. vi190–vi191). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/nox168.771

Popovski, Dean, Catherine R. Cochrane, Elizabeth M. Algar, Anette Szczepny, W Samantha Jayasekara, David M. Ashley, Peter Downie, D Neil Watkins, and Jason E. Cain. “PDTM-06. TARGETED CATALYTIC INHIBITION OF EZH2 SYNERGIZES WITH LOW-DOSE PANOBINOSTAT IN MALIGNANT RHABDOID TUMOR.” In Neuro-Oncology, 19:vi190–91. Oxford University Press (OUP), 2017. https://doi.org/10.1093/neuonc/nox168.771.

Popovski D, Cochrane CR, Algar EM, Szczepny A, Jayasekara WS, Ashley DM, et al. PDTM-06. TARGETED CATALYTIC INHIBITION OF EZH2 SYNERGIZES WITH LOW-DOSE PANOBINOSTAT IN MALIGNANT RHABDOID TUMOR. In: Neuro-Oncology. Oxford University Press (OUP); 2017. p. vi190–1.

Popovski, Dean, et al. “PDTM-06. TARGETED CATALYTIC INHIBITION OF EZH2 SYNERGIZES WITH LOW-DOSE PANOBINOSTAT IN MALIGNANT RHABDOID TUMOR.” Neuro-Oncology, vol. 19, no. suppl_6, Oxford University Press (OUP), 2017, pp. vi190–91. Crossref, doi:10.1093/neuonc/nox168.771.

Popovski D, Cochrane CR, Algar EM, Szczepny A, Jayasekara WS, Ashley DM, Downie P, Watkins DN, Cain JE. PDTM-06. TARGETED CATALYTIC INHIBITION OF EZH2 SYNERGIZES WITH LOW-DOSE PANOBINOSTAT IN MALIGNANT RHABDOID TUMOR. Neuro-Oncology. Oxford University Press (OUP); 2017. p. vi190–vi191.